Haili Qian[Author] - Search Results

Year	Number of Results
2004	1
2005	1
2006	3
2007	7
2008	2
2009	2
2011	2
2012	3
2013	6
2014	10
2015	5
2016	7
2017	2
2018	4
2019	4
2020	12
2021	9
2022	10
2023	9
2024	2

1

Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling.

Li C, Qiu S, Liu X, Guo F, Zhai J, Li Z, Deng L, Ge L, Qian H, Yang L, Xu B. Li C, et al. Among authors: qian h. Signal Transduct Target Ther. 2023 Jun 28;8(1):247. doi: 10.1038/s41392-023-01453-0. Signal Transduct Target Ther. 2023. PMID: 37369642 Free PMC article.

2

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming.

Wang T, Sun F, Li C, Nan P, Song Y, Wan X, Mo H, Wang J, Zhou Y, Guo Y, Helali AE, Xu D, Zhan Q, Ma F, Qian H. Wang T, et al. Among authors: qian h. Adv Sci (Weinh). 2023 Sep;10(25):e2300756. doi: 10.1002/advs.202300756. Epub 2023 Jul 13. Adv Sci (Weinh). 2023. PMID: 37442756 Free PMC article.

3

Biological effects of radiation on cancer cells.

Wang JS, Wang HJ, Qian HL. Wang JS, et al. Mil Med Res. 2018 Jun 30;5(1):20. doi: 10.1186/s40779-018-0167-4. Mil Med Res. 2018. PMID: 29958545 Free PMC article. Review.

4

Mesoscience in cell biology and cancer research.

Qian H, Beltran AS. Qian H, et al. Cancer Innov. 2022 Nov 17;1(4):271-284. doi: 10.1002/cai2.33. eCollection 2022 Dec. Cancer Innov. 2022. PMID: 38089088 Free PMC article. Review.

5

MTA1: A Vital Modulator in Prostate Cancer.

Ma J, Li C, Qian H, Zhang Y. Ma J, et al. Among authors: qian h. Curr Protein Pept Sci. 2022;23(7):456-464. doi: 10.2174/1389203723666220705152713. Curr Protein Pept Sci. 2022. PMID: 35792131 Review.

6

A hidden translatome in tumors-the coding lncRNAs.

Wang J, Wang W, Ma F, Qian H. Wang J, et al. Among authors: qian h. Sci China Life Sci. 2023 Dec;66(12):2755-2772. doi: 10.1007/s11427-022-2289-6. Epub 2023 May 5. Sci China Life Sci. 2023. PMID: 37154857 Review.

7

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.

Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, Zhai JT, Qian HL, Ma F. Li YQ, et al. Mil Med Res. 2023 Jul 25;10(1):34. doi: 10.1186/s40779-023-00470-y. Mil Med Res. 2023. PMID: 37491281 Free PMC article.

8

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency.

Sun D, Feng F, Teng F, Xie T, Wang J, Xing P, Qian H, Li J. Sun D, et al. Among authors: qian h. Cell Commun Signal. 2023 Mar 3;21(1):48. doi: 10.1186/s12964-023-01065-9. Cell Commun Signal. 2023. PMID: 36869329 Free PMC article.

9

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels.

Qian H. Qian H. Mol Ther Oncolytics. 2022 Nov 16;27:203. doi: 10.1016/j.omto.2022.10.008. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36420305 Free PMC article. No abstract available.

10

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy.

Sun D, Qian H, Li J, Xing P. Sun D, et al. Among authors: qian h. J Biomed Sci. 2024 Jan 29;31(1):17. doi: 10.1186/s12929-024-01004-x. J Biomed Sci. 2024. PMID: 38281981 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year